![Michael Landsittel](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Michael Landsittel
Director/Board Member at
DAMORA THERAPEUTICS, INC.
Profile
Currently, Michael Landsittel holds the position of Chief Financial Officer for Blueprint Medicines Corp. In his past career Mr. Landsittel held the position of Finance Director of Infinity Pharmaceuticals, Inc. and Senior Director-Finance at Algeta US LLC. Mr. Landsittel received an undergraduate degree from the University of Michigan and an MBA from Tuck School of Business at Dartmouth.
Michael Landsittel active positions
| Companies | Position | Start |
|---|---|---|
| DAMORA THERAPEUTICS, INC. | Director/Board Member | 23/03/2026 |
Former positions of Michael Landsittel
| Companies | Position | End |
|---|---|---|
| BLUEPRINT MEDICINES CORPORATION | Director of Finance/CFO | 01/11/2025 |
Algeta US LLC
 Algeta US LLC Pharmaceuticals: MajorHealth Technology Engages in developing, manufacturing and marketing novel targeted therapies for patients with cancer | Director of Finance/CFO | 01/07/2014 |
| INFINITY PHARMACEUTICALS, INC. | Corporate Officer/Principal | 01/10/2012 |
Training of Michael Landsittel
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
90
1st degree connections
6
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 6 |
|---|---|
Infinity Pharmaceuticals, Inc.
 Infinity Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company that develops medicines for the treatment of cancer | Health Technology |
University of Michigan
 University of Michigan Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Blueprint Medicines Corp.
 Blueprint Medicines Corp. BiotechnologyHealth Technology Develops cancer therapies that harness the growing understanding of the molecular blueprint of cancer | Health Technology |
Tuck School of Business at Dartmouth
 Tuck School of Business at Dartmouth Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Algeta US LLC
Algeta US LLC Pharmaceuticals: MajorHealth Technology Engages in developing, manufacturing and marketing novel targeted therapies for patients with cancer | Health Technology |
Galecto, Inc.
 Galecto, Inc. Pharmaceuticals: MajorHealth Technology Develops drugs for treatment of severe diseases | Health Technology |
- Stock Market
- Insiders
- Michael Landsittel
